EGT [Entertainment Gaming Asia] 8-K: CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com

[CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com 872/802-4227 RESULTS AND ENTERTAINMENT GAMING ASIA INC. REPORTS FIRST QUARTER 2015 PROVIDES MARKET UPDATE - Company Reports Profitable First Quarter of 2015 – Hong Kong – May 14, 2015 – Entertainment Gaming Asia Inc. (NASDAQ: EGT) (“Entertainment Gaming Asia” or “the Company”), a gaming company focused on emerging gaming markets in Pan-Asia,] [ENTERTAINMENT GAMING ASIA INC. Nevada 001-32161 91-1696010 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification Number) Unit C1, Ground Floor, Koon Wah Building No. 2 Yuen Shun Circuit Yuen Chau Kok, Shatin New Territories, Hong Kong SAR + 852-3147-6600 Not applicable (Former name or former address, if changed since last report) o o o o Item 2.02 Results of]

By | 2016-04-02T04:36:58+00:00 May 14th, 2015|Categories: Chinese Stocks, EGT, Webplus ver|Tags: , , , , , |0 Comments

CREG [CHINA RECYCLING ENERGY] 10-Q:

[] [CERTIFICATIONS I, Guohua Ku, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, David Chong, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Guohua Ku Chairman of the Board and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. David Chong Chief Financial Officer and Secretary]

By | 2016-03-14T14:59:00+00:00 May 14th, 2015|Categories: Chinese Stocks, CREG, Webplus ver|Tags: , , , , , |0 Comments

NTES [NetEase] 6-K: (Original Filing)

[Contact for Media and Investors: Cassia Curran NetEase, Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports First Quarter 2015 Unaudited Financial Results (Beijing — May 13, 2015) — NetEase, Inc. (NASDAQ: NTES), one of China’s leading Internet and online game services providers, today announced its unaudited financial results for the first quarter ended] [FORM 6-K NETEASE, INC. 26/F, SP Tower D Form 20-F x Form 40-F o o o NETEASE, INC. Form 6-K TABLE OF CONTENTS Page]

By | 2016-03-26T14:13:35+00:00 May 14th, 2015|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase] 6-K: Contact for Media and Investors: Cassia Curran NetEase,

[Contact for Media and Investors: Cassia Curran NetEase, Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports First Quarter 2015 Unaudited Financial Results (Beijing — May 13, 2015) — NetEase, Inc. (NASDAQ: NTES), one of China’s leading Internet and online game services providers, today announced its unaudited financial results for the first quarter ended] [FORM 6-K NETEASE, INC. 26/F, SP Tower D Form 20-F x Form 40-F o o o NETEASE, INC. Form 6-K TABLE OF CONTENTS Page]

By | 2016-03-26T14:15:00+00:00 May 14th, 2015|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Resignation of an Independent Director HONG KONG, China, May 14, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that Mr. Julian J. Wolhardt, one of the Company’s independent directors, has resigned] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description 99.1]

By | 2016-03-27T08:52:31+00:00 May 14th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities BEIJING, May 14, 2014 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company received site inspection notification for the commercial production facilities of its EV71 vaccine candidate from the China Food and Drug Administration (CFDA). This notification represents a significant step] []

By | 2016-03-16T06:30:07+00:00 May 14th, 2015|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Resignation of an

[China Cord Blood Corporation Announces Resignation of an Independent Director HONG KONG, China, May 14, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that Mr. Julian J. Wolhardt, one of the Company’s independent directors, has resigned] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description 99.1]

By | 2016-03-27T08:53:44+00:00 May 14th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Receives Site Inspection Notification for EV71 Vaccine

[Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities BEIJING, May 14, 2014 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company received site inspection notification for the commercial production facilities of its EV71 vaccine candidate from the China Food and Drug Administration (CFDA). This notification represents a significant step] []

By | 2016-03-16T06:31:13+00:00 May 14th, 2015|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar